Combined Low-pass Whole Genome and Targeted Sequencing Identifies Causative Mutations and Associated Genomic Scarring Indicative of Homologous Recombination Deficiency | Labcorp Oncology Skip to main contentScroll Back to Top
Our global life sciences company brings diagnostic testing & drug development together.